Sign in

CIK 0001815974 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Anebulo Pharmaceuticals, Inc.

Sign in to watch
Ticker
ANEB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Jun 30
Incorporated
DE
Entity type
operating
EIN
851170950
Phone
737 203 5270
Business address
C/O ANEBULO PHARMACEUTICALS, INC., 1017 RANCH ROAD 620 SOUTH, SUITE 107, LAKEWAY, TX, 78734
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 8-K Event Other events
  8. 10-Q Report Quarterly Report
  9. 8-K Event Results of operations
  10. 4/A Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 10-Q Report Quarterly Report
  13. 8-K Event Results of operations
  14. 4 Grant or award Director acquired 300,000 shares (grant or award)
  15. 8-K Event Shareholder vote results
  16. 10-Q Report Quarterly Report
  17. 8-K Event Results of operations
  18. ARS Other Annual Report to Security Holders
  19. DEF 14A Proxy Proxy Statement
  20. PRE 14A Proxy Proxy Statement (Preliminary)

Page 5 of 11 · 204 filings